Q4 2023 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2024-02-14 · accession 0000902664-24-001731
$22.5M
Reported value
6
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 500946108 | KRRO | KORRO BIO INC | $13.3M | 58.9% | 276,831 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $2.7M | 12.1% | 474,067 | Common | SHARED |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $2.6M | 11.6% | 172,600 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $1.5M | 6.52% | 65,933 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $1.4M | 6.22% | 549,981 | Common | SHARED |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $1.1M | 4.72% | 352,941 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.